Melhores Terapia direcionada Terapia direcionada em Israel - TOP-22 médicos

A Dra. Pelles Sharon é uma oncologista respeitada com vasta experiência em terapia-alvo e outros tratamentos avançados de câncer no Sourasky Medical Center.

• Especializada em terapia-alvo para vários tipos de câncer
• Contribuiu para pesquisas clínicas sobre as atitudes de pacientes oncológicos em relação a ensaios clínicos
• Realiza múltiplos tratamentos avançados de câncer, incluindo terapia SIRT e HIPEC
• Trabalha no Sourasky Medical Center (Ichilov), um importante hospital israelense

O Professor Ofer Merimsky lidera a unidade de Oncologia de Tecidos Moles e Ósseos no Sourasky Medical Center – o principal especialista em sarcoma de Israel.

• Mais de 30 anos tratando sarcomas com terapias direcionadas
• Fellowship (bolsa de estudo/especialização) em sarcoma no Institut Gustave Roussy, Paris
• Membro do corpo docente da ESMO para pesquisa de sarcoma
• Publicou extensivamente sobre oncologia ortopédica
• Ex-presidente da Sociedade Israelense de Oncologia

O Dr. Sarid publicou mais de 30 artigos sobre terapia do câncer e lidera ensaios clínicos em tratamentos direcionados no Sourasky Medical Center.

• Especialista em quimioterapia, radioterapia e terapia biológica para diversos tipos de câncer
• Mais de 15 anos como oncologista sênior no Ichilov Medical Center
• Professor na Universidade de Tel Aviv – mantém-se atualizado com as terapias mais recentes
• Membro da ESMO e da ASCO – segue as diretrizes internacionais de tratamento

Especialista em Ginecologia Oncológica e Radioterapia no Sourasky Medical Center (Ichilov) com foco na terapia direcionada.

• Experiente em tratamentos de precisão para cânceres ginecológicos
• Utiliza técnicas avançadas de radioterapia para tratamento direcionado
• Parte de uma equipe de oncologia líder em um centro médico de excelência

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

O Dr. Raphael lidera a Iniciativa Nacional de Medicina Genômica de Israel e é pioneiro em ensaios de terapia alvo no Sourasky Medical Center.

• Especialista em neoplasias torácicas e perfil genômico abrangente
• Investigador principal de múltiplos ensaios clínicos de imunoterapia
• Moderador do Molecular Tumor Board da Sociedade Israelense de Câncer de Pulmão
• Beneficiário de bolsas de pesquisa da ESMO e IASLC
• Desenvolve técnicas de biópsia líquida para monitoramento de tratamento

O Dr. Ido Wolf lidera a Divisão de Oncologia Médica no Sourasky Medical Center, sendo especializado em terapia-alvo.

• Chefe da Divisão de Oncologia Médica em um hospital israelense de referência
• Vasta experiência em oncologia e medicina interna
• Formado na Universidade Ben Gurion do Neguev
• Seu histórico inclui serviço em Unidades Médicas do Exército

Diretor do Serviço de Neuro-oncologia no Centro Médico Sourasky – O Dr. Blumental acumula décadas de experiência especializada em neuro-oncologia.

• Treinamento no Memorial Sloan-Kettering Cancer Center
• Neuro-oncologista sênior desde 1998
• Anteriormente dirigiu o Serviço de Neuro-oncologia no Huntsman Cancer Institute

O Dr. Fredi Aviv possui 31 anos de experiência focada em onco-hematologia no Centro Médico Sourasky.

• Especializa-se em tratamentos oncológicos direcionados para distúrbios sanguíneos
• Trabalha na Clínica Ichilov – um centro líder em oncologia hematológica
• Vasta experiência com novas abordagens terapêuticas

O Dr. Dror Levin é especializado no tratamento de distúrbios sanguíneos e câncer ósseo em crianças no Sourasky Medical Center, um dos principais hospitais de Israel.

• Diretor do departamento de hematologia oncológica pediátrica no Sourasky Medical Center
• Coordena o tratamento de câncer ósseo (sarcoma) em crianças
• Treinado no Instituto Ortopédico Rizzoli na Itália – líder mundial
• Membro da ISPHO (Sociedade Israelense de Hematologia Oncológica Pediátrica)

Diretor de hospitalização oncológica no Centro Médico de Tel Aviv, Ichilov – O Dr. Stepfansky lidera equipes de tratamento do câncer.

• Mais de 20 anos de experiência em oncologia e medicina interna
• Pesquisador em múltiplas fases de ensaios clínicos em oncologia
• Especializado em medicina interna e oncologia em Ichilov

O Dr. Amir é especialista em terapia direcionada com Keytruda (Pembolizumab) para câncer de mama, apoiado por mais de 30 apresentações em encontros científicos.

• Ganhador do Prêmio ESMO de Pesquisa Translacional em Câncer de Mama em 2013
• Formação de fellowship no Instituto Jules Bordet e na Universidade Emory
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Pesquisa publicada reconhecida duas vezes com o Prêmio ISCORT de Melhor Artigo do Ano

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Médico Chefe do Centro de Oncologia no Assuta Medical Center – especialista líder em terapia direcionada.

• Especializa-se em tratamentos de oncologia de precisão
• Vasta experiência com terapias personalizadas contra o câncer
• Trabalha em um dos principais centros oncológicos de Israel

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.